Influenza vaccine (BiondVax)

N/A

Report date: 2025/10/23 20:00:06

Base Information

Drug NameInfluenza vaccine (BiondVax)

Drug Alias NameMultimeric-001 Universal Flu Vaccine (BiondVax)流感疫苗 - BiondVaxMultimeric Multi-Epitope Polypeptide Influenza Vaccine (BiondVax)Universal Flu Vaccine (BiondVax)BVX-M001 +[6]

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPolandHungary +[4]

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWeizmann Institute Of Science

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiondVax Pharmaceuticals Ltd National Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A